Trails Edge Capital Partners, LP 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-21 4:30 pm Purchase | 2025-07-14 | 13G | Milestone Pharmaceuticals Inc. MIST | Trails Edge Capital Partners, LP | 8,847,882 9.900% | 8,847,882 (New Position) | Filing |